GENENTECH, INC. and CITY OF HOPE, Plaintiffs and Counterclaim Defendants,
v.
AMGEN INC., Defendant and Counterclaim Plaintiff,
GENENTECH, INC. and CITY OF HOPE, Plaintiffs and Counterclaim Defendants,
v.
SAMSUNG BIOEPSIS CO., LTD., Defendant and Counterclaim Plaintff.
United States District Court, D. Delaware.https://leagle.com/images/logo.png
This action arises under the Biologics Price Competition and Innovation Act ("BPCIA"), 42 U.S.C. § 262, and involves biosimilar versions of Herceptin®, a drug used to treat breast cancer. Pending before me is the matter of claim construction pursuant to Markman v. Westview...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.